STOCK TITAN

If You Invested in Definitive Healthcare Corp. (DH)

Services-prepackaged Software · Health Information Services · NASDAQ
$1,000 invested 1 Year Ago
$430
-57.0% total -57.5% CAGR
Bought on Apr 7, 2025 at $2.51
$1,000 invested 5 Years Ago
$25
-97.5% total -55.6% CAGR
Bought on Sep 15, 2021 at $43.29

Custom Calculation

Choose your own date and amount for DH

$1,000 Investment Over Time

DH vs S&P 500

Year-by-Year Returns

DH annual performance
Year Start Price End Price Annual Return Cumulative
2021 $43.29 $27.33 -36.9% -36.9%
2022 $28.15 $10.99 -61.0% -74.6%
2023 $11.20 $9.94 -11.2% -77.0%
2024 $10.15 $4.11 -59.5% -90.5%
2025 $4.12 $2.87 -30.3% -93.4%
2026 $2.38 $1.08 -54.5% -97.5%

About Definitive Healthcare Corp.

Services-prepackaged Software · NASDAQ

Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on the business side of the U.S. healthcare market. The company describes itself as an industry leader in healthcare commercial intelligence, providing information and insights that help organizations make smarter, faster and more strategic decisions across the healthcare ecosystem.

According to the company, the healthcare market is complex, and its data is intended to make that market clearer for customers. Definitive Healthcare states that it transforms data, analytics and expertise into healthcare commercial intelligence so clients can uncover the right markets, opportunities and people and shape tomorrow’s healthcare industry.

Business model and platform

Definitive Healthcare operates a SaaS-based healthcare commercial intelligence platform. As described in its public materials, the platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the United States. The company notes that its products and solutions create new paths to commercial success in the healthcare market, helping companies identify where to go next.

The platform uses deep analytics and data science to help customers develop data-driven strategic decisions. Examples cited by the company include finding new markets to enter, building go-to-market strategies, accessing tactical information to target appropriate decision makers, and improving win rates with detailed contextual information.

Definitive Healthcare reports that it derives substantially all of its revenue from subscription fees for access to its platform and stand-ready support. This subscription model aligns with its description of SaaS products and solutions that customers use on an ongoing basis.

End markets and use cases

Across its disclosures and press releases, Definitive Healthcare highlights that it serves a range of healthcare-related end markets. It references customer wins with organizations such as medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms, and healthcare advertising agencies. These examples illustrate how different types of organizations use its data, insights and integrations to support their critical business use cases.

The company emphasizes that its data and analytics help clients:

  • Uncover the right markets and opportunities in the healthcare sector
  • Identify and engage the right people and decision makers
  • Support go-to-market execution and sales targeting
  • Inform diligence and investment strategies in healthcare
  • Support service line expansion, physician recruitment and telemedicine growth for providers

Industry positioning and sector classification

Definitive Healthcare describes itself as a healthcare commercial intelligence and healthcare market data and analytics company. Based on the provided classification, it operates within the Professional, Scientific, and Technical Services sector and the industry category of Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology).

The company’s focus is on the information and analytics needs of the healthcare market rather than on direct patient care or the development of drugs or devices. Its role, as described in its own materials, is to cut through the noise of the healthcare market and deliver insights that organizations and companies can use to make more informed commercial decisions.

Geographic focus

Definitive Healthcare’s platform is described as providing information on the healthcare ecosystem in the United States. The company also notes that it derives a majority of its revenue from the United States, underscoring that its commercial intelligence and data assets are primarily oriented around the U.S. healthcare market.

Stock information and corporate structure

Definitive Healthcare Corp. is incorporated in Delaware and its common stock trades on the NASDAQ under the ticker symbol DH. SEC filings list its corporate name as Definitive Healthcare Corp. and confirm its status as a Delaware corporation.

Management, governance and disclosures

Through its SEC filings, the company discloses changes in its board and executive leadership, such as the resignation of directors, changes in committee roles, and adjustments to executive positions. It also reports inducement equity awards granted to senior leaders under its inducement plan, consistent with Nasdaq Listing Rule 5635(c)(4). These disclosures provide insight into how Definitive Healthcare manages executive compensation and leadership transitions.

The company regularly issues earnings press releases and files related Form 8-K reports to furnish financial results for its quarters and to provide financial guidance. These communications include discussions of non-GAAP financial measures such as Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow, along with explanations of why management uses these metrics to evaluate performance.

Financial communication and non-GAAP metrics

In its earnings releases, Definitive Healthcare explains that it uses non-GAAP financial measures to focus on the performance of its core operations and to facilitate comparisons to historical periods and to other companies. The company provides definitions for metrics such as:

  • Adjusted EBITDA and Adjusted EBITDA Margin
  • Adjusted Gross Profit and Adjusted Gross Margin
  • Adjusted Operating Income
  • Adjusted Net Income and Adjusted Net Income Per Diluted Share
  • Unlevered Free Cash Flow

It also notes that these measures are supplemental, are not prepared in accordance with U.S. GAAP, and should not be considered substitutes for GAAP measures like net income, loss from operations, or cash provided by operating activities.

Investor communications and events

Definitive Healthcare frequently participates in investor conferences and hosts quarterly earnings calls and webcasts. The company announces the timing of these events in press releases and makes live audio webcasts available. It also states that it intends to use its website as a distribution channel for material company information, and that financial and other important information regarding the company is routinely posted and accessible there.

Status and continuity

Recent press releases and Form 8-K filings show that Definitive Healthcare continues to operate as a publicly traded company on NASDAQ under the symbol DH, reporting quarterly financial results, issuing financial guidance and making leadership and compensation disclosures. There is no indication in the provided materials of delisting, deregistration, bankruptcy, or completed merger transactions.

Market Cap
$0.1B
Current Price
$1.08
EPS
$-1.30
Revenue
$0.2B
Net Margin
-57.5%
View full DH overview

Frequently Asked Questions

Definitive Healthcare Corp. investment returns

How much would $1,000 invested in Definitive Healthcare Corp. be worth today?

If you invested $1,000 in Definitive Healthcare Corp. (DH) 10 years ago on 2021-09-15, your investment would be worth $25 today, representing a -97.5% total return, growing at a compounded rate of -55.6% per year (CAGR).

Has Definitive Healthcare Corp. outperformed the S&P 500?

Over the past 10 years, DH returned -97.5% compared to +221.2% for the S&P 500, underperforming the benchmark by 318.7 percentage points.

What is Definitive Healthcare Corp.'s average annual return?

The compound annual growth rate (CAGR) of DH over the past 10 years is -55.6%, growing at a compounded rate each year. Individual years vary significantly — DH's best recent year was 2023 (-11.2%) and worst was 2022 (-61.0%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.